Skip to Main Content

Paper Details

Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized Trial.
Int J Radiat Oncol Biol Phys
1
2024
BM, Brain Metastases, Breast Cancer, HER2, HER2+, HER2+ breast cancer, Lapatinib, Patients, brain metastases, breast cancer, human, human epidermal, human epidermal growth factor receptor 2, lapatinib, patients
Author NameAffiliation
David M PeereboomBrain Tumor & Neuro-Oncology Cleveland Clinic Main Campus
Serah ChoiUniversity Hospitals Cleveland Medical Center and Case Comprehensive Cancer Center
Joshua D PalmerOhio State University Wexner Medical Center
Minesh P MehtaMiami Cancer Institute
  • 1 - 4

Datasets

Release 1.2